Tech Company Financing Transactions
EnPlusOne Biosciences Funding Round
EnPlusOne Biosciences closed a $12 million Seed venture capital round on 9/30/2022. Backers included Northpond Ventures, Breakout Ventures and Coatue Management.
Transaction Overview
Company Name
Announced On
9/30/2022
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to build out its team and platform capabilities in line with the its mission to enable next-generation solutions for emerging RNA therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
313 Pleasant St. 4W
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Overview
Chemical synthesis cannot keep pace with RNA innovation. Our proprietary ezRNA� platform builds RNA enzymatically and promises long-term manufacturing solutions to sustainably deliver RNA therapeutics at scale.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Wiegand
Chief Operating Officer
Dan Ahlstedt
Chief Scientific Officer
Jonathan Rittichier
Co-Founder
George Church
Co-Founder
Howon Lee
Browse more venture capital transactions:
Prev: 9/30/2022: Labrador CMS venture capital transaction
Next: 9/30/2022: Pulp Culture venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs